[Federal Register Volume 61, Number 11 (Wednesday, January 17, 1996)]
[Notices]
[Pages 1191-1192]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-487]



-----------------------------------------------------------------------

[[Page 1192]]



DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Vaccine Advisory Committee (NVAC), Subcommittee on 
Vaccine Safety and the Advisory Commission on Childhood Vaccines (ACCV) 
Subcommittee on Vaccine Safety, Subcommittee on Immunization Coverage, 
and Subcommittee on Future Vaccines: Meetings

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following Federal advisory committee 
meetings.

    Name: National Vaccine Advisory Committee (NVAC).
    Times and Dates: 8:30 a.m.-2:30 p.m., January 22, 1995. 8:30 
a.m.-1 p.m., January 23, 1996.
    Place: Savoy Suites Georgetown, 2505 Wisconsin Avenue, NW, 
Washington, DC 20007.
    Status: Open to the public, limited only by the space available.
    Purpose: The Committee shall advise and make recommendations tot 
he Director of the National Vaccine Program on matters related to 
the Program responsibilities.
    Matters to be Discussed: The Committee will receive an update on 
the National Vaccine Program Office and National Vaccine Advisory 
Committee operations; update on the Interagency Task Force on 
Vaccine Safety and funding for acting surveillance; update on 
immunization deliver: insights from recent research on vaccine 
coverage and a report on the new Women, Infants, and Childrens 
demonstration projects; update on vaccine program funding; update 
from the subcommittee on immunization coverage; proposal for a 
potential solution to the problem of an increasing menu of pediatric 
vaccines; defining a vaccine manufacturer/government partnership; 
update on adult immunization strategies and priorities; report on 
the influenza pandemic plan; role of the NVAC in fostering the 
pandemic influenza plan; update on the future vaccines subcommittee; 
presentation on the presence of reverse transcriptase activity in 
vaccine products; status of the Advisory Committee on Immunization 
Practices reevaluation of polio immunization recommendations and 
adolescent immunization; update on the injury compensation system; 
an update on USAID; and an information presentation on recent 
immunization compensation cases impacting immunization.

    Name: Subcommittee on Vaccine Safety and the Advisory Commission 
on Childhood Vaccines Subcommittee on Vaccine Safety.
    Time and Date: 2:30 p.m.-5 p.m., January 22, 1996
    Place: Savoy Suites Georgetown, 2505 Wisconsin Avenue, NW, 
Washington, DC 20007.
    Status: Open to the public, limited only by the space available.
    Purpose: This joint ACCV/NVAC subcommittee will review issues 
relevant to vaccine safety and adverse reactions to vaccines.
    Matters to be Discussed: The Subcommittee will discuss the 
Institute of Medicine vaccine safety forum and summary of planned 
workshops; the task force on safer childhood vaccines; and the 
charge of the Subcommittees.

    Name: Subcommittee on Immunization Coverage.
    Time and Date: 2:30 p.m.-5 p.m., January 22, 1996
    Place: Savoy Suites Georgetown, 2505 Wisconsin Avenue, NW, 
Washington, DC 20007.
    Status: Open to the public, limited only by the space available.
    Purpose: The Subcommittee on Immunization Coverage will identify 
strategies and policy options by which to further improve the levels 
of immunization coverage.
    Matters to be Discussed: The Subcommittee will discuss 
determinants of under vaccination in preschool children; national, 
State, and local immunization coverage levels; current interventions 
for immunization and the future health environment.

    Name: Subcommittee on Future Vaccines.
    Time and Date: 2:30 p.m.-5 p.m., January 22, 1996.
    Place: Savoy Suites Georgetown, 2505 Wisconsin Avenue, NW, 
Washington, DC 20007.
    Status: Open to the public, limited only by the space available.
    Purpose: The Subcommittee on Future Vaccines will develop policy 
options and guide national activities which will lead to accelerated 
development, licensure, and best use of new vaccines in the simplest 
possible immunization schedules.
    Matters to be Discussed: The Subcommittee will review and 
discuss the terms of reference for the Subcommittee; identify the 
matrix of interactions and partnerships, via specific case studies; 
describe the process of priority-setting by each of the members of 
the vaccine research and development community, and define barriers 
to new vaccine development.
    Agenda items for each meeting are subject to change as 
priorities dictate.
    The shutdown of the Federal Government prevented meeting the 15-
day publication requirement.
    Contact Person for More Information: Gloria A. Kovach, Committee 
Management Specialist, National Vaccine Program Office, CDC, 1600 
Clifton Road, NE, M/S A20, Atlanta, Georgia 30333, telephon 404/639-
3851.

    Dated: January 10, 1996.
Carolyn J. Russell,
Director, Management Analysis and Services Office Centers for Disease 
Control and Prevention (CDC).
[FR Doc. 96-487 Filed 1-11-96; 8:45 am]
BILLING CODE 4163-18-M